Full-Time

Clinical Pharmacist-Sterile Products

Confirmed live in the last 24 hours

Cleveland Clinic

Cleveland Clinic

Non-profit academic medical center providing healthcare

No salary listed

Mid, Senior

Company Does Not Provide H1B Sponsorship

Cleveland, OH, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • PharmD or Bachelors of Science degree in Pharmacy from an accredited college of pharmacy
  • Current State licensure as a Registered Pharmacist (RPh) or eligible for reciprocation in current State within 90 days of hire
  • Board Certification preferred
  • Current Basic Life Support (BLS) certification through American Heart Association (AHA) for individuals required to administer immunizations
  • Completion of a Board of Pharmacy approved course in the administration of immunizations or certification obtained within 90 days of hire for individuals required to administer immunizations
  • Current Advanced Cardiovascular Life Support (ACLS) or Pediatric Advanced Life Support (PALS) Certification through American Heart Association (AHA) for individuals required to respond to adult or pediatric cardiopulmonary arrest events, or certification obtained within one (1) year of hire
  • Completion of a post-graduate year 1 residency (PGY1), fellowship or 2 years of relevant post-graduate pharmacy experience required
Responsibilities
  • Assure accuracy of compounded sterile products
  • Observe and correct aseptic technique and compounding practices
  • Manage sterile compounding personnel and workflow to assure efficient, safe, and timely delivery of compounded sterile products
  • Review and verify adult parenteral nutrition orders
  • Manage emergent orders from OR suites and critical response teams
  • Review and verify specialty medication orders including prostacyclins and factor products
  • Review and verify orders for assigned ambulatory infusion suites
  • Identify and respond to shifts in use patterns to minimize waste and maximize productivity
  • Continually improve work standards within the Sterile Products Team to support patient safety and operational efficiency
  • Advance knowledge of regulatory requirements and trends governing compounding
  • Assure completion and documentation of all required activities
  • Provides safe, efficient, patient-centered, evidence-based medication services
  • Verifies medication orders and/or dispenses medications accurately according to state and federal regulations
  • Documents services in a complete, accurate and timely manner
  • Actively contributes to medication safety initiatives
  • Utilizes available technology proficiently and to full extent, in their area of practice
  • Ensures all pharmacy operations are in compliance with national accreditation standards
  • Maintains professional interactions with patients to facilitate successful patient experiences
  • Directs staff appropriately to provide safe and efficient care
  • Maintains professional working relationships with all caregivers
  • Promotes a positive work environment by providing constructive ideas and feedback to improve services and the department
  • Educates and trains students, residents, other caregivers, and/or patients
  • Provides cost-effective care
  • Accountable for drug use policy adherence
  • Utilizes time and resources effectively
  • Other duties as assigned
Desired Qualifications
  • Post-graduate year 2 residency (PGY2) or relevant experience preferred for Clinical Pharmacists hired in a Specialized Pharmacy practice area (i.e. Critical Care, Oncology)

Cleveland Clinic is a non-profit academic medical center that provides high-quality clinical and hospital care, including routine check-ups, specialized treatments, and life-saving surgeries. It offers virtual visits and second opinions to improve accessibility and operates multiple locations in Ohio, Florida, Abu Dhabi, and Canada. The clinic generates revenue primarily through patient services and enhances the patient experience with resources like MyChart for health record management. Cleveland Clinic aims to deliver exceptional medical care, advance medical research, and educate future healthcare professionals.

Company Size

N/A

Company Stage

Grant

Total Funding

$74.7M

Headquarters

Cleveland, Ohio

Founded

1921

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased investment in AI healthcare solutions enhances Cleveland Clinic's data analysis capabilities.
  • Neuromodulation therapies present opportunities for treating conditions like obstructive sleep apnea.
  • Collaboration on virtual neighborhoods using EHR data offers community health insights.

What critics are saying

  • Competition from AI healthcare companies may challenge Cleveland Clinic's data management.
  • Neuromodulation therapies could shift patient preferences from traditional treatments.
  • Developing virtual neighborhoods with EHR data may pose data privacy challenges.

What makes Cleveland Clinic unique

  • Cleveland Clinic offers comprehensive medical services, including virtual visits and second opinions.
  • It operates globally with facilities in Ohio, Florida, Abu Dhabi, and Canada.
  • The clinic supports healthcare providers with resources like DrConnect and eRadiology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Mental Health Support

Company News

Finsmes
Dec 12th, 2024
1m Raises $10M in Series A Funding

1m raises $10M in Series A funding.

Hit Consultant
Oct 24th, 2024
Dyania Health Secures $10M for AI-Powered Chart Review

Dyania Health, an AI-powered healthcare data company, today announced the close of its $10 million Series A funding round led by Health..

PR Newswire
Aug 21st, 2024
Xii Medical Raises $45 Million In Series B Financing To Advance Best-In-Class Neuromodulation Therapy For Obstructive Sleep Apnea

Omega Funds and Intuitive Ventures join top-tier syndicate of healthcare investors to support ongoing clinical activitiesUNION CITY, Calif., Aug. 21, 2024 /PRNewswire/ -- XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep apnea, today announced the closing of a $45 million Series B equity financing. The financing was led by Omega Funds and joined by new investor Intuitive Ventures. Existing investors also participated, including founding investor Cleveland Clinic, Ajax Health, Longview Ventures (an affiliate of Broadview Ventures), Aperture Venture Partners, JobsOhio Growth Capital Fund and an undisclosed strategic investor. Funds will be utilized to further product and clinical development. XII Medical has developed a state-of-the-art, patient-centric neuromodulation therapy designed to enhance quality of life for the millions of people suffering from obstructive sleep apnea.Obstructive sleep apnea (OSA) is a disorder in which the muscles in the throat temporarily relax, causing blockage of the airway during sleep

Finsmes
Aug 6th, 2024
Neurotherapia Raises $12.3M In Series B Funding

NeuroTherapia, a Cleveland, OH-based clinical-stage company focused on developing therapies for neurodegenerative diseases, raised $12.3M in Series B funding.The round was led by Cleveland Clinic, and included all previous investors, Brain Trust Accelerator Fund II, Dolby Family Ventures and the Alzheimer’s Drug Discovery Foundation (ADDF) as well as new investors, Foundation for a Better World and CRUINT. Led by President and CEO Tony Giordano, NeuroTherapia is a clinical-stage biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system (CNS), including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and other CNS conditions. NeuroTherapia is developing therapeutics that inhibit microglia cells, which are known to express proteins that drive inflammation in the CNS, without affecting the clearance of toxic beta amyloid.The company intends to use the funds for the continued clinical development of NTRX-07, an orally available cannabinoid receptor agonist, for the treatment of Alzheimer’s disease (AD). NeuroTherapia will continue to raise additional funds for its second close in six months, which will enable development of a recently discovered second generation molecule for a separate indication in which neuroinflammation plays a major role.FinSMEs06/08/2024

PR Newswire
Aug 1st, 2023
Enspire DBS Therapy Announces $17.6 Million Series B Financing to Advance the Development of Deep Brain Stimulation (DBS) plus Rehabilitation for Stroke Patients

/PRNewswire/ -- Enspire DBS Therapy, Inc., (Enspire) a clinical stage company developing an implantable neuromodulation therapy for post-stroke recovery,...